Mad in America is a webzine devoted to rethinking psychiatry’s current “disease model” for diagnosing and treating psychiatric disorders. This Parent Resources section is designed to provide information and resources for parents who wish to explore alternatives to conventional, drug-based psychiatric care for children and youth.
Question of the Week
Did you know:
- That longer-term studies of children given a diagnostic label of ADHD have found worseoutcomes for medicated youth?
- In a large NIMH study, researchers concluded that few youth “benefit long-term” from antipsychotics (neuroleptic drugs)?
- That marijuana, stimulants, and antidepressants increase the risk that a youth will receive a diagnostic label of bipolar disorder?
Research on psychotropic use in children and adolescents
- Stimulants for children with a diagnostic label of ADHD
- Antidepressants for children with a diagnostic label of depression/anxiety
- Antipsychotics (neuroleptics) for children with a diagnostic label of psychosis, bipolar disorder, and more
Research on non-pharmacological treatments
In this webinar, Dr. Adam Urato, a practicing OB-GYN, reviews the risks of SSRI use during pregnancy. He details the role that serotonin plays in normal fetal development, and reviews the extensive literature, from both animal studies and human studies, that warns of potential harm to the fetus and newborn child from exposure to a drug that disrupts normal serotonin function. Dr. Urato also discusses the financial conflicts of interest that have led to a societal failure to warn pregnant women of this risk.